HCV Response in Patients With End Stage Renal Disease Treated With Combination Pegylated Interferon α-2a and Ribavirin

GOALS: To determine the efficacy and safety of combination therapy in patients with hepatitis C virus (HCV) and end-stage renal disease (ESRD). BACKGROUND: There is little data on the treatment of ESRD patients with pegylated interferon and ribavirin. We designed a pilot study to determine the initi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hakim, Wyel, Sheikh, Shehzad, Inayat, Irteza, Caldwell, Cary, Smith, Douglas, Lorber, Marc, Friedman, Amy, Jain, Dhanpat, Bia, Margaret, Formica, Richard, Mehal, Wajahat
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715868/
https://ncbi.nlm.nih.gov/pubmed/19142165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0b013e318180803a
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires